Anxiety Disorders and Symptoms study: Personalized MAYA Mobile App vs General MAYA Mobile App
Official title Personalized Mobile Cognitive Behavioral Therapy Application
ClinicalTrials.gov ID: NCT05699525
What this study is testing
- What it's testing
- This study is testing whether a personalized app works as well as a standard one. It looks at how well each helps with anxiety and depression symptoms.
- Who it's for
- You may be able to join if you have anxiety, depression, or bipolar disorder symptoms.
- What's involved
- You would use the Maya app for 20 minutes, two days a week. You would also do weekly check-ins and fill out questionnaires.
- Time commitment
- The study lasts six weeks and includes weekly check-ins with the team.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 25
You may be able to join if
- Age between 18 and 25 years.
- Primary diagnosis of an anxiety, depressive, or bipolar disorder as determined by a score of 4 or greater on the Clinical Severity Rating of the...
- If an individual is diagnosed with bipolar disorder, they must be currently euthymic or experiencing a depressive episode.
- Access to an Apple iPhone, iPad, or Android device.
You likely can't join if
- History of neurologic disorder that may affect the neural systems of interest or participant's ability to participate
- Lifetime diagnosis of a psychotic disorder.
- Current hypomanic or manic episode.
- Currently in cognitive behavior therapy.
- Change in dose of a psychiatric medication in the past 12 weeks.
- Initiation of psychotherapy in the past 12 weeks.
See the full eligibility criteria
- Age between 18 and 25 years.
- Primary diagnosis of an anxiety, depressive, or bipolar disorder as determined by a score of 4 or greater on the Clinical Severity Rating of the Anxiety Disorders Interview Schedule (ADIS).
- If an individual is diagnosed with bipolar disorder, they must be currently euthymic or experiencing a depressive episode.
- Access to an Apple iPhone, iPad, or Android device.
- History of neurologic disorder that may affect the neural systems of interest or participant's ability to participate
- Lifetime diagnosis of a psychotic disorder.
- Current hypomanic or manic episode.
- Currently in cognitive behavior therapy.
- Change in dose of a psychiatric medication in the past 12 weeks.
- Initiation of psychotherapy in the past 12 weeks.
- Intent or plan to attempt suicide.
The study team makes the final eligibility decision.
Where it is enrolling
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 25 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at New York, New York, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.